tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FTRE Stock Latest News

Fortrea completes $75.7M senior notes tender offer
The FlyFortrea completes $75.7M senior notes tender offer
10d ago
FTRE
Fortrea Holdings Completes Oversubscribed Debt Tender Offer
PremiumCompany Announcements
Fortrea Holdings Completes Oversubscribed Debt Tender Offer
14d ago
8K
FTRE
Fortrea appoints Gallagher as General Counsel
PremiumThe Fly
Fortrea appoints Gallagher as General Counsel
17d ago
FTRE
Starboard takes new stake in Bill Holdings, exits Pfizer position
PremiumThe Fly
Starboard takes new stake in Bill Holdings, exits Pfizer position
20d ago
HR
BDX
Cautious Outlook for Fortrea Holdings Inc. Amid 2026 Challenges and Potential 2027 Recovery
PremiumRatings
Cautious Outlook for Fortrea Holdings Inc. Amid 2026 Challenges and Potential 2027 Recovery
24d ago
FTRE
Fortrea price target raised to $12 from $10 at Citi
PremiumThe FlyFortrea price target raised to $12 from $10 at Citi
24d ago
FTRE
Fortrea price target raised to $11 from $9 at Mizuho
Premium
The Fly
Fortrea price target raised to $11 from $9 at Mizuho
27d ago
FTRE
Fortrea price target raised to $14 from $11 at Evercore ISI
Premium
The Fly
Fortrea price target raised to $14 from $11 at Evercore ISI
28d ago
FTRE
Fortrea Holdings Reports Q3 2025 Earnings and Raises Guidance
PremiumCompany Announcements
Fortrea Holdings Reports Q3 2025 Earnings and Raises Guidance
28d ago
FTRE
Fortrea Holdings Inc. Navigates Growth and Challenges in Q3 Earnings Call
PremiumCompany Announcements
Fortrea Holdings Inc. Navigates Growth and Challenges in Q3 Earnings Call
28d ago
FTRE
Fortrea raises FY25 revenue view to $2.700B-$2.750B from $2.600-$2.700
PremiumThe Fly
Fortrea raises FY25 revenue view to $2.700B-$2.750B from $2.600-$2.700
29d ago
FTRE
Fortrea reports Q3 adjusted EPS 12c, consensus 16c
PremiumThe Fly
Fortrea reports Q3 adjusted EPS 12c, consensus 16c
29d ago
FTRE
Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection
PremiumCompany AnnouncementsFortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection
1M ago
FTRE
Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption
Premium
Company Announcements
Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption
1M ago
FTRE
Fortrea’s Phase 3 Study on AP301: A Potential Game-Changer for Hyperphosphatemia Treatment
Premium
Company Announcements
Fortrea’s Phase 3 Study on AP301: A Potential Game-Changer for Hyperphosphatemia Treatment
1M ago
FTRE
Fortrea’s Givinostat Study: A New Hope for Young DMD Patients
PremiumCompany Announcements
Fortrea’s Givinostat Study: A New Hope for Young DMD Patients
1M ago
FTRE
Fortrea’s Phase 1 PET Study: A Potential Game-Changer in Diagnostic Imaging
PremiumCompany Announcements
Fortrea’s Phase 1 PET Study: A Potential Game-Changer in Diagnostic Imaging
1M ago
FTRE
Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy
PremiumCompany Announcements
Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy
1M ago
FTRE
Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery?
PremiumCompany Announcements
Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery?
1M ago
FTRE
Fortrea announces debt tender offer for up to $75.7M aggregate purchase price
PremiumThe FlyFortrea announces debt tender offer for up to $75.7M aggregate purchase price
1M ago
FTRE
Fortrea price target raised to $9 from $7 at Mizuho
Premium
The Fly
Fortrea price target raised to $9 from $7 at Mizuho
2M ago
FTRE
Fortrea price target raised to $11 from $7 at Evercore ISI
Premium
The Fly
Fortrea price target raised to $11 from $7 at Evercore ISI
2M ago
FTRE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >